Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05502237 |
|---|---|
| Brief Title: | Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer (STAR-121) |
| First Submitted : | August 12, 2022 |
| First Submitted that Met QC Criteria : | August 12, 2022 |
| First Posted : | August 16, 2022 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 1, 2024 |